INNOVA CAPTAB
|
The Current P/E Ratio of INNOVA CAPTAB is 37.29.
Share Price | ₹836.2 | Jun 19,2025 |
Market Cap | ₹4,782.8 Cr | |
Earnings-TTM | ₹128.3 Cr | TTM-Consolidated Results |
Price/Earnings | 37.29x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of INNOVA CAPTAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,782.8 Cr] as on Jun 19,2025
(/) Earnings [ ₹128.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 37.29x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay 37.29 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INNOVA CAPTAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INNOVA CAPTAB over the last five years.
Historical PE (Price/Earnings) ratio chart of INNOVA CAPTAB
PE Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 5.44x.
- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2024 at 27.18x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
INNOVA CAPTAB | 128.26 | 37.29 | 4,782.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.00 | 395,254.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 78.67 | 172,374.0 |
CIPLA LTD | 5,291.05 | 22.64 | 119,795.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 56.11 | 107,218.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.41 | 110,698.0 |
MANKIND PHARMA LTD | 2,003.22 | 47.86 | 95,866.6 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.71 | 95,577.1 |
LUPIN LTD | 3,306.26 | 26.69 | 88,256.4 |
AUROBINDO PHARMA LTD | 3,515.26 | 17.90 | 62,915.3 |
ABBOTT INDIA LTD | 1,414.44 | 46.59 | 65,898.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INNOVA CAPTAB 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.90x |
Max industry PE | 78.67x |
Median industry PE | 36.00x |
Average industry PE | 37.26x |
You may also like the below Video Courses